ASPAC III Acquisition Corp.
Company Information
Industry
Blank Checks
SIC Code
6770
Entity Type
operating
SEC Category
Emerging growth company
State of Incorporation
Virgin Islands, British
Business Address
200 GLOUCESTER ROAD, WANCHAI, K3, 00000
Mailing Address
200 GLOUCESTER ROAD, WANCHAI, K3, 00000
Phone
852 9258 9728
Fiscal Year End
1231
EIN
000000000
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | March 30, 2026 | View on SEC |
| 10-K Annual financial report | March 4, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 12, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 12, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 11, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 6, 2026 | View on SEC |
| 8-K Current report of material events | January 23, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | November 14, 2025 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | November 13, 2025 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | November 13, 2025 | View on SEC |
Annual Reports
10-K
March 4, 2026
- Proposed merger with Bioserica International Limited, valued at $217.86 million, aims to transform ASPAC III into an operating entity in the growing bio-based antimicrobial sector.
- Strong liquidity with $60.0 million in the trust account and no long-term debt, ensuring capital availability for the business combination or shareholder redemptions.
Related Companies
Companies in the same industry (SIC: 6770)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.